ACA Therapeutics is a St. Petersburg, Florida-based clinical-stage biopharmaceutical company reimagining the future of medicine.

We are dedicated to resolving the fundamental drivers of cancer and chronic diseases by utilizing our proprietary Upstream-Midstream-Downstream (UMD) Framework. Unlike traditional approaches focused on lifelong symptom management, we target the root causes of illness, restoring systemic health and reducing drug dependence.

Our mission is to deliver "The People’s Science”—accessible, high-potency therapies that dramatically reduce drug costs and systemic toxicity, making life-saving treatments a reality for all patients. We maintain a robust pipeline of 42+ Phase I Ready indications, covering oncology, neurology (Alzheimer’s/Parkinson’s), and metabolic restoration, guided by a world-class Scientific Advisory Board.

ACA-001 (Pancreatic Cancer) | ACA Therapeutics

Product description

ACA Therapeutics St. Petersburg, United States (US)

Price: N/A

ACA Therapeutics
St. Petersburg, United States (US)